Open-Label, Randomised, Parallel-Group, Multicentre Study to Evaluate the Safety, Tolerability and Immunogenicity of an AS03B/oil-in-water Emulsion-Adjuvanted (AS03B) Split-Virion Versus Non-Adjuvanted Whole-Virion H1N1 Influenza Vaccine in UK Children 6 Months to 12 Years of Age

Health Technology Assessment - United Kingdom
doi 10.3310/hta14460-01

Related search